Mark L. Berch

Array ( [id] => 1101977 [patent_doc_number] => 06815446 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-09 [patent_title] => 'Selective antagonists of A2B adenosine receptors' [patent_app_type] => B1 [patent_app_number] => 09/648775 [patent_app_country] => US [patent_app_date] => 2000-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5158 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815446.pdf [firstpage_image] =>[orig_patent_app_number] => 09648775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535694 [patent_doc_number] => 06489470 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Process for the preparation of cefpodoxime proxetil diastereoisomers' [patent_app_type] => B1 [patent_app_number] => 09/582896 [patent_app_country] => US [patent_app_date] => 2000-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4727 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489470.pdf [firstpage_image] =>[orig_patent_app_number] => 09582896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1349741 [patent_doc_number] => 06583283 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Polymorphic forms of cipamfylline' [patent_app_type] => B1 [patent_app_number] => 09/529865 [patent_app_country] => US [patent_app_date] => 2000-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 8212 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583283.pdf [firstpage_image] =>[orig_patent_app_number] => 09529865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1451428 [patent_doc_number] => 06455699 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Camptothecin analogs and methods of preparation thereof' [patent_app_type] => B1 [patent_app_number] => 09/633561 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16518 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 408 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455699.pdf [firstpage_image] =>[orig_patent_app_number] => 09633561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560834 [patent_doc_number] => 06437119 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Compounds formed from two or three antibiotics and their processes of preparation' [patent_app_type] => B1 [patent_app_number] => 09/618106 [patent_app_country] => US [patent_app_date] => 2000-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3186 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437119.pdf [firstpage_image] =>[orig_patent_app_number] => 09618106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4743 [patent_doc_number] => 07816525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-10-19 [patent_title] => 'Process for the preparation of optically pure tetrahydropterins and derivatives, and specifically of optically pure tetrahydrofolic acid and derivatives thereof, by stereospecific hydrogenation' [patent_app_type] => utility [patent_app_number] => 10/030692 [patent_app_country] => US [patent_app_date] => 2000-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14687 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816525.pdf [firstpage_image] =>[orig_patent_app_number] => 10030692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348419 [patent_doc_number] => 06579868 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes' [patent_app_type] => B1 [patent_app_number] => 09/582840 [patent_app_country] => US [patent_app_date] => 2000-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34383 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579868.pdf [firstpage_image] =>[orig_patent_app_number] => 09582840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596195 [patent_doc_number] => 06384214 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Process for producing cephalosporin derivatives' [patent_app_type] => B1 [patent_app_number] => 09/610647 [patent_app_country] => US [patent_app_date] => 2000-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5865 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384214.pdf [firstpage_image] =>[orig_patent_app_number] => 09610647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1063309 [patent_doc_number] => 06849735 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Methods of synthesis for 9-substituted hypoxanthine derivatives' [patent_app_type] => utility [patent_app_number] => 09/602048 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 6644 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849735.pdf [firstpage_image] =>[orig_patent_app_number] => 09602048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7642294 [patent_doc_number] => RE037721 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents' [patent_app_type] => E1 [patent_app_number] => 09/594996 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12049 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037721.pdf [firstpage_image] =>[orig_patent_app_number] => 09594996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625442 [patent_doc_number] => 06723727 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them' [patent_app_type] => B1 [patent_app_number] => 09/594033 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24079 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723727.pdf [firstpage_image] =>[orig_patent_app_number] => 09594033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021807 [patent_doc_number] => 06887881 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Bispidine compounds useful in the treatment of cardiac arrythmias' [patent_app_type] => utility [patent_app_number] => 09/623709 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15893 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887881.pdf [firstpage_image] =>[orig_patent_app_number] => 09623709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490636 [patent_doc_number] => 06417175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Phosphonocephem derivatives, process for the preparation of the same, and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/555949 [patent_app_country] => US [patent_app_date] => 2000-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12932 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417175.pdf [firstpage_image] =>[orig_patent_app_number] => 09555949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551722 [patent_doc_number] => 06399770 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Preparation of -hydroxy esters using ammonium borohydrides' [patent_app_type] => B1 [patent_app_number] => 09/555859 [patent_app_country] => US [patent_app_date] => 2000-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3492 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399770.pdf [firstpage_image] =>[orig_patent_app_number] => 09555859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680671 [patent_doc_number] => 07084268 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-01 [patent_title] => 'Carbapenem compound crystals and interjection preparations' [patent_app_type] => utility [patent_app_number] => 09/979679 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 11714 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084268.pdf [firstpage_image] =>[orig_patent_app_number] => 09979679 [rel_patent_id] =>[rel_patent_doc_number] =>)